Abstract
This study is a controlled of locally applied DSCG in 18 cases troublesome allergic conjunctivitis. DSCG, in a 3% solution, instilled into each patients eye 4 times daily.
1. 14 cases out of 18 improved their complete loss of eye symptoms. 11 cases were within 3 days, 2 cases were within 7 days and 1 case was within 2 weeks.
2. 1 case out of 18 responded with immediate mild stinging after instillation of the drops, but instillation of eye drops, 2 times daily, seemed succesful and after 4 weeks troublesome eye symptoms were partially reduced.
3. 3 cases out of 18 were not useful, 2 cases complained severe stinging after instillation of the drops and 1 case developed local swelling around the eye lids.
4. When instillation of eye drops was discontinued, allergic eye symptoms developed afterward. DSCG ophthalmic solution was not succesful in controlling allergic conjunctivitis completely.
5. There are no known side effects from DSCG ophthalmic solution as cortico-steroid.
We consider that DSCG ophthalmic solution is a useful method for the treatment of allergic conjunctivitis.
